Percutaneous coronary intervention (PCI) has become a reliable revascularization option to treat advanced coronary artery disease (CAD) [1]. Several recent trials suggest that PCI with metallic drug-eluting stents (DESs) is feasible and safe and has equivalent long-term outcomes compared to coronary artery bypass grafting (CABG) for the treatment of lesser complex LM stenosis [2,3].,
Department of Cardiology

Everaert, B., Capranzano, P., Tamburino, C., Seth, A., & Van Geuns, R.-J.M. (Robert-Jan M.). (2017). Left main interventions with BRSs. In Bioresorbable Scaffolds: From Basic Concept to Clinical Applications (pp. 326–331). doi:10.1201/9781315380629